Skip to main content
Why not end your patient visit with a recitation pledging your service and commitment:
"Your coming to see me to day is

Dr. John Cush RheumNow

3 years 7 months ago
Why not end your patient visit with a recitation pledging your service and commitment: "Your coming to see me to day is very important, to the both of us. I pledge to be of service to you. Together WE can certainly improve your health" https://t.co/HrzbipL1ZG https://t.co/amDCk309wi
JAK-pot Study: To Cycle or Switch after JAK inhibitor Failure?

Data from 17 international registries suggest that for

Dr. John Cush RheumNow

3 years 7 months ago
JAK-pot Study: To Cycle or Switch after JAK inhibitor Failure? Data from 17 international registries suggest that for RA patients failing their first JAKi, it did not matter if they were cycled to another JAKi or switched to a bDMARD. https://t.co/WunRxeF5Wm https://t.co/cOIjglnPNU
Subanalysis of Scleroderma Lung Study II (MMP vs CTX in SSc-ILD) showed pt reported GI reflux (~moderate) was independen

Dr. John Cush RheumNow

3 years 7 months ago
Subanalysis of Scleroderma Lung Study II (MMP vs CTX in SSc-ILD) showed pt reported GI reflux (~moderate) was independently associated with the change ILD and fibrosis over two years (but not so for esophageal dilation) https://t.co/5Gz2vfOock https://t.co/N2FsvNe24M
AS, but not PsA, has Increased Mortality Risk

A recent meta-analysis showed a significantly increased risk of overall

Dr. John Cush RheumNow

3 years 7 months ago
AS, but not PsA, has Increased Mortality Risk A recent meta-analysis showed a significantly increased risk of overall mortality in ankylosing spondylitis (AS) but not psoriatic arthritis (PsA), largely associated with cardiovascular-specific mortality. https://t.co/bi3q7LW4S6 https://t.co/DUc9sB4MI0
Simon Says “Don’t Do This”

Dr. Jack Cush reviews this week’s journal articles, focuses on studies that should

Dr. John Cush RheumNow

3 years 7 months ago
Simon Says “Don’t Do This” Dr. Jack Cush reviews this week’s journal articles, focuses on studies that should not have been done and responds to viewer questions in Ask Cush Anything. https://t.co/ZisyCRxV6L https://t.co/inYDkKKJO3
CDC: Nursing home residents not up to date w/COVID-19 vaccines have 30%–50% higher risk for COVID infx vs those up to

Dr. John Cush RheumNow

3 years 7 months ago
CDC: Nursing home residents not up to date w/COVID-19 vaccines have 30%–50% higher risk for COVID infx vs those up to date. Betw 2022-23 Those vax had COVID rate of 7.2-15.6/1000pts vs 9.5-18.8/1000 pt in those unvaccinated. https://t.co/Eem2H5AMoN https://t.co/o2ZyPVswZp
VEXAS may be more common than expected

A great study of a recently described rheumatologic/hematologic disorder VEXAS

Dr. John Cush RheumNow

3 years 7 months ago
VEXAS may be more common than expected A great study of a recently described rheumatologic/hematologic disorder VEXAS syndrome recently appeared in JAMA, describing the frequency and presentations of UBA1 variant. https://t.co/OFaeH62eHy https://t.co/7znps74Llv
A group of researchers from the Graduate School of Medicine at Nagoya University in Japan have discovered the impact of microRNA (miRNA) on inflammation in lupus in mice. They identified two miRNAs that are downregulated in the disease and an uncommon situation that occurs in which multiple miRNAs regulate the same set of genes.  
Blood Test Identifies Osteoarthritis Progression

A new blood test that can identify progression of osteoarthritis in t

Dr. John Cush RheumNow

3 years 7 months ago
Blood Test Identifies Osteoarthritis Progression A new blood test that can identify progression of osteoarthritis in the knee is more accurate than current methods, providing an important tool to advance research and speed discovery of new therapies. https://t.co/hOAjxJhnJG https://t.co/Ehr5imPNQ4
A Shortage of Trust

I’ve oft heard the truism that “Trust is in short supply”. This is so true. Those I value m

Dr. John Cush RheumNow

3 years 7 months ago
A Shortage of Trust I’ve oft heard the truism that “Trust is in short supply”. This is so true. Those I value most, are the ones I trust the most. My nurse practitioner, my front desk gal, my medical partner, and my best friend... https://t.co/AXIDAJQUta https://t.co/GJwQq04dUC
Dr. Jack Cush reviews this week’s journal articles, focuses on studies that should not have been done and responds to viewer questions in Ask Cush Anything.
Join us on 3/18 and 3/19 in Dallas, Texas or virtually for RheumNow Live!

Who is coming?

https://t.co/LLUufQDhHv https

Dr. John Cush RheumNow

3 years 7 months ago
Join us on 3/18 and 3/19 in Dallas, Texas or virtually for RheumNow Live! Who is coming? https://t.co/LLUufQDhHv https://t.co/nKTN5KBtuc
Variable Pregnancy Outcomes with Belimumab in SLE

An analysis looked at outcomes in pregnant SLE exposed to belimumab

Dr. John Cush RheumNow

3 years 7 months ago
Variable Pregnancy Outcomes with Belimumab in SLE An analysis looked at outcomes in pregnant SLE exposed to belimumab reported there are few pregnancies and confounding disease and comorbidity factors to provide clear guidance for such patients. https://t.co/pkyAcE0aNr https://t.co/MB4AGmtSdp
702 #SLE pts (age 29 yrs) from India, measured plasma 25-hydroxyvitamin-D(25(OH)D) - median levels were 22.83 (13.8–31

Dr. John Cush RheumNow

3 years 7 months ago
702 #SLE pts (age 29 yrs) from India, measured plasma 25-hydroxyvitamin-D(25(OH)D) - median levels were 22.83 (13.8–31.8) ng/ml. Low Vit D(< 20) seen in 41.5%; correlated w/ age/geography, & weak neg correlation w/ weak negative correlation w/ SLEDAI2K https://t.co/EUPqJGKAhI https://t.co/MEIL5yd64n
×